Clinical Trials Logo

Clinical Trial Summary

It is a phase II trial, randomized, parallel, double blind, multicenter, comparing riluzole versus placebo. The trial population is composed of patients ≥18 years old that have developed stage II/III colorectal cancer and are eligible for Simplified FOLFOX4 (6-12 cycles) adjuvant chemotherapy. The primary objective is to assess the preventive efficacy of riluzole on the severity of oxaliplatin-induced peripheral neuropathy during the Simplified FOLFOX4 adjuvant chemotherapy of stage II/III colorectal cancers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Oxaliplatin-induced Peripheral Neuropathy
  • Peripheral Nervous System Diseases

NCT number NCT03722680
Study type Interventional
Source UNICANCER
Contact
Status Active, not recruiting
Phase Phase 2
Start date October 28, 2020
Completion date October 28, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04751513 - Auricular Acupressure : Improves Oxaliplatin-induced Peripheral Neuropathy N/A